EndoNurse Magazine - endoscopy, gastroenterology, colonoscopy, colon cancer, gastroesophageal reflux disease, colitis, Crohn’s disease , polyps, inflammatory bowel disease, irritable bowel syndrome, endoscope

FEATURES

Heartburn May Predict Throat Cancer

PHILADELPHIA—Frequent heartburn was positively associated with cancers of the throat and vocal cord among nonsmokers and nondrinkers, and the use of antacids, but not prescription medications, had a protective effect, ...read more

Communicate Better at Work

In today’s fast-paced nursing environment every word matters. Make yours count. Choose your words wisely and be successful at work. ...read more

Choosing and Using the Proper Probiotic

This slide show will be helpful to GI professionals who want to learn more about probiotics, and can be shared with patients as well. ...read more

May is Celiac Awareness Month

This May (and every May, for that matter) is Celiac Awareness Month. This awareness campaign is sponsored by the National Foundation for Celiac Awareness and other celiac organizations. ...read more

Latest Headlines

Data Presented at Digestive Disease Week on Two Otsuka Products in Development for Inflammatory Bowel Disease

NEW ORLEANS -- Otsuka America Pharmaceutical, Inc. (OAPI) and Otsuka Maryland Research Institute, Inc. (OMRI) have announced that data are being presented on two investigational products in development for treating gastrointestinal disease at Digestive Disease Week (DDW) ...More
May 21, 2004
Posted in News, Disorders, Industry Issues, Procedures
Significant Symptom Relief Reported in Cilansetron Phase III Clinical Trial Patients with Irritable Bowel Syndrome with Diarrhea Predominance (IBS-D)

NEW ORLEANS -- In a six-month study of both male and female IBS-D patients, treatment with cilansetron resulted in significant relief of abdominal pain/discomfort and abnormal bowel habits. Additionally, in a sub-group analysis of male patients, data shows significant ...More
May 21, 2004
Posted in News, Disorders, Industry Issues, Procedures
Microbia Presents Data on Novel Drug Candidate With Potential to Treat Irritable Bowel Syndrome

NEW ORLEANS -- Microbia, Inc. has presented preclinical data demonstrating that its novel-mechanism therapeutic candidate to treat irritable bowel syndrome (IBS) effectively relieves gastrointestinal pain and promotes gastrointestinal transit, the key defining attributes of ...More
May 21, 2004
Posted in News, Disorders, Industry Issues, Procedures
DrugVoice Introduces IBSTracker to Study Changing IBS Marketplace

ANDOVER, Mass. -- DrugVoice announces IBSTracker, a new study exploring the dynamic IBS market. This study assesses the changing attitudes and behaviors of 500 IBS patients over a one-year period. DrugVoice is currently offering clients the option to pre-enroll in this ...More
May 21, 2004
Posted in News, Disorders, Industry Issues
Tumor Suppressor Gene Family May be Key to New Colon Cancer Drugs

In the hunt for new cancer drug targets, scientists from the Johns Hopkins Kimmel Cancer Center and the Howard Hughes Medical Institute have discovered mutations in a family of genes linked to more than a quarter of colon cancers, as well as several other common cancers ...More
May 21, 2004
Posted in News, Disorders, Industry Issues, Procedures
A New Way to Kill Cancer: Viruses Can Destroy Lung, Colon Tumors

A genetically engineered virus can selectively kill cancerous cells in the lung and colon while leaving healthy cells intact, according to new research published in Cancer Research by William Wold and colleagues at Saint Louis University School of Medicine. The research ...More
May 20, 2004
Posted in News, Disorders, Industry Issues, Procedures
Even Health-conscious Women Going Without Colonoscopy

Many women who regularly get checked for breast cancer and cervical cancer still don’t go for a test that could save them from another big killer -- colon cancer – according to new University of Michigan research. But perhaps their mammogram and Pap smear appointments could ...More
May 20, 2004
Posted in News, Disorders, Industry Issues, Procedures
Researchers Advance Fight Against Pancreatic Cancer

Two Dartmouth medical studies have produced promising results in the fight against pancreatic cancer, one of the most deadly and aggressive forms of cancer, and may lead to the development of new, highly targeted therapies to manage previously untreatable tumors. In two ...More
May 20, 2004
Posted in News, Disorders, Industry Issues
Rb2/VEGF Expression Could Be Liver Cancer Prognosticators

The expression of the tumor-suppressing gene Rb2/p130 and the protein Vascular Endothelial Growth Factor (VEGF) in hepatocellular carcinoma (liver cancer) could serve as important independent prognostic markers in determining the aggressiveness of the cancer, according to ...More
May 20, 2004
Posted in News, Disorders, Industry Issues
Key Results: 2004 IFFGD IBS Survey of 1,000 Americans

MILWAUKEE, WI — In March 2004, the International Foundation for Functional Gastrointestinal Disorders (IFFGD) conducted a survey of 1,000 Americans asking questions about awareness of and experience with the symptoms of Irritable Bowel Syndrome (IBS). Following are key ...More
May 20, 2004
Posted in News, Disorders, Industry Issues, Procedures